PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-May-2022 New EFSA opinion offers future FSMP application potential for Bimuno® prebiotic ingredient Clasado Biosciences
03-May-2022 BD to Showcase its Deep Commitment to Drug Delivery Excellence at Pharmapack B3C newswire
03-May-2022 HAEMATO AG: Dividend of EUR 1.10 HAEMATO AG
03-May-2022 F-star Therapeutics to Announce First Quarter Results and Host Conference Call on Tuesday, May 10th, 2022 F-star Therapeutics
03-May-2022 HUTCHMED Receives Complete Response Letter from the U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors HUTCHMED
03-May-2022 CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development B3C newswire
03-May-2022 Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) Horizon Therapeutics
03-May-2022 Publication of Annual Report and Financial Statements for the Year ended 31 December 2021 Acacia Pharma Group
03-May-2022 MIMETAS Expands Adult Stem Cell Organoid License to All Organs B3C newswire
03-May-2022 Watson-Marlow Fluid Technology Solutions and the National Institute for Bioprocessing Research and Training partner for biopharma training programme Sciad Newswire
03-May-2022 Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership Medartis Holding AG
03-May-2022 COSMO ANNOUNCES EXPANDING THE AGREEMENT WITH MEDTRONIC FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA Cosmo Pharmaceuticals N.V.
02-May-2022 MediClin AG: Group sales for the 1st quarter of 2022 significantly above the previous year's figure MediClin AG
02-May-2022 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
02-May-2022 Biotest AG: Biotest Supervisory Board appoints new Management Board member Biotest AG
02-May-2022 IGEA Pharma N.V.: IGEA to get SIX approval to delay the 2021 annual report disclosure IGEA Pharma N.V.
30-Apr-2022 Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021 Vita 34 AG
29-Apr-2022 Xlife Sciences publishes annual results 2021 and outlook 2022 Xlife Sciences AG
29-Apr-2022 Vita 34 publishes revenue and earnings forecast for the 2022 financial year Vita 34 AG
29-Apr-2022 CHEPLAPHARM CONTINUES PROFITABLE GROWTH TRACK IN 2021 AS WELL Cheplapharm AG